Newsbot

Regional bank CEO on private credit, impacts from AI

2026 might be off to a rocky start as investors digest Greenland threats, impending Supreme Court tariff and Federal Reserve-related cases, and the first row of fourth-quarter earnings. And as earnings season always starts, the big banks report first, followed by the regional banks. No doubt, ...

IntraBio erhält Zulassung der Europäischen Kommission für AQNEURSA® zur Behandlung der Niemann-Pick-Krankheit Typ C

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc. gab heute bekannt, dass die Europäische Kommission die Marktzulassung für AQNEURSA® (Levacetylleucin) zur Behandlung neurologischer Symptome der Niemann-Pick-Krankheit Typ C (NPC) erteilt hat. Die Zulassung folgt auf eine positive Stellungnahme des Ausschusses für Humanarzneimittel (CHMP) der Europäischen Arzneimittelagentur (EMA). AQNEURSA® ist in der Europäischen Union zur Behandlung von Erwachsenen und Kindern ab 6 Jahren mit einem Körpergewicht

Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells 9,067 Shares of Stock

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) CFO Oluyemi Okupe sold 9,067 shares of the companys stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $30.34, for a total value of $275,092.78. Following the sale, the chief financial officer owned 91,617 shares of the companys stock, valued at $2,779,659.78. This represents a 9.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange C...

Anthropic CEO goes nuclear on Nvidia

In November 2025, Nvidia (NVDA) said it would invest up to $10 billion in Anthropic. The company also stated it will help optimize Anthropic models for performance, efficiency, and total cost of ownership. Anthropic’s artificial intelligence models have been trained on Nvidia GPUs, Amazon Trainium ...

Kimco Realty Corporation Announces 2025 Dividend Tax Treatment

JERICHO, N.Y., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Kimco Realty® (NYSE: KIM), a real estate investment trust (REIT) and leading owner and operator of high-quality, open-air, grocery-anchored shopping centers and mixed-use properties in the United States, announced today the 2025 tax treatment of its common stock and preferred stock dividend distributions. The allocations as they will be reported on Form 1099-DIV are as follows:

IntraBio verkündet positive Ergebnisse der Zulassungsstudie für Levacetylleucin zur Behandlung von Ataxia-Telangiectasia

AUSTIN, Texas--(BUSINESS WIRE)--IntraBio Inc. verkündete heute positive Topline-Ergebnisse der klinischen Phase-III-Zulassungsstudie IB1001-303, „Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Randomized, Placebo-Controlled, Double-Blind, Crossover Study“ (NCT06673056) zur Bewertung von N?Acetyl?L?Leucin (Levacetylleucin) für pädiatrische und erwachsene Patienten mit Ataxia-Telangiectasia (A-T). Der primäre Endpunkt der Studie bewertete die Wirkung der Behandlung mit Levacetyll

Kinder Morgan KMI Q4 2025 Earnings Call Transcript

Image source: The Motley Fool.DateJan. 21, 2026 at 4:30 p.m. ETCall participantsPresident — Thomas A. MartinChief Financial Officer — David Patrick MichelsSenior Vice President, Corporate Development — Theresa ChenPresident, Natural Gas Pipelines — Sital K. ModyNeed a quote from a Motley Fool analyst? Email pr@fool.comTakeawaysNet income and EPS -- Net income attributable to Kinder Morgan (NYSE:KMI) was $996 million, and earnings per share (EPS) was $0.45, representing increases of 49% and ...